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THE PIONEERING work of Aird, Bentall and Roberts demonstrated a significant
excess of blood group A in patients with carcinoma of the stomach. Blood group
distribution in diseases of the central nervous system has received little attention.
Strang, in the only reported investigation on Parkinson's disease, found an increased
incidence of blood group 0 in a series of 450 patients in Sweden. This paper presents
a statistical analysis of the ABO, blood group distribution of patients with Parkin-
son's disease in Northern Ireland.
MATERIALS
The data are from the hospital records of 187 patients (98 women and 89 men)
treated for Parkinson's disease in the Department of Neurological Surgery, Royal
Victoria Hospital, Belfast, and these were considered representative of the disease
in the community. Comparison is made with a control series of 27,650, blood donors
from the same population.
TABLE I
Comparison of ABO blood group distribution of 187 patients with Parkinson's
disease with that of the 27,650 controls.
Blood Patients Controls
Group Total No. Percentage. Total No. Percentage 2
0 100 53.48 14,931 54.00 0.009
A 48 25.67 9,152 33.09 3.113
B 30 16.04 2,765 10.00 6.828
AB 9 4.81 802 2.91 2.329
Total 187 100.00 27,650 100.00 12.279
Total x2= 12.279 d.f. =3 0.01>P>0.001
RESULTS
Table I shows the distribution of ABO blood groups in 187 patients with
Parkinson's disease compared with that found in the 27,650 controls. A larger
number of patients with Parkinson's disease had blood group B, and a smaller
number blood group A. The Chi2 test gave a p value <0.01, indicating that these
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Parkinson's Disease.
Relative incidence in persons of Group 0 and B compared with incidence of
one in persons of Group A (derived by Woolf's method).
Blood Group Relative Incidence X2 p
0 1.28 1.964 0.2 >P>0.1
B 1.62 5.335 0.05>P>0.02*
*Statistically significant.
differences were significant to a highly probable degree. Group 0 distribution was
approximately the same in the two series. Further consideration of the small
excess of group AB was deferred because of the relatively small numbers.
The relative incidence of blood groups 0 and B compared with group A in
patients with Parkinson's disease is given in Table II. The relative incidence of
group B compared with group A was significantly greater than unity (P<0.05) and
probably significant though not to a highly probable degree.
DIscussIoN
Woolf's method has been used to compare and combine these data with the
Swedish figures as reported by Strang. The number of patients from Finland and
Norway in Strang's paper was considered to be too small to be included in this
analysis (Table IHI).
TABLE III
Calculation of combined estimate of incidence ratio of Parkinson's Disease
in blood groups 0 and A
Total number of Relative
Country patients incidence X2 P
(O+A) 0:A
N. Ireland 148 1.28 1.9643 0.2 >P>0.1
Sweden 388 1.32 7.2104 0.01>P>0.001
x2 Analysis: Total x2 d.f.=2 9.1747 0.02>P>0.01
Heterogeneity d.f.=1 0.0364 0.9 >P>0.8
Diff. from unity d.f.=1 9.1383 0.01>P>0.001
In Sweden the incidence of blood group 0 in patients with Parkinson's disease
is significantly greater than that of blood group A. The Northern Ireland data
reveal a low incidence of blood group A as compared with blood group 0, and a
high incidence of group B in patients with Parkinson's disease. Combination of
these two sets of data reveals a similar incidence ratio of Parkinson's disease in
133both the populations (O;:A). However, this is significant only in the Swedish series
(P<0.01). Obviously further studies are needed in different geographical areas on
similar lines before any deductions can be put forward. It is towards this end that
the present study was undertaken.
SUMMARY
The ABO blood group distribution in 187 patients with Parkinson's disease in
Northern Ireland showed a deficiency of blood group A and an excess of blood
group B, when compared with the controls.
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